HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
Hosaka T, Suzuki F, Kobayashi M, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.
Hosaka T, et al. Among authors: hirakawa m.
Liver Int. 2010 Nov;30(10):1461-70. doi: 10.1111/j.1478-3231.2010.02344.x. Epub 2010 Sep 14.
Liver Int. 2010.
PMID: 20840396